US Stock MarketDetailed Quotes

GRI Bio (GRI)

Watchlist
  • 1.470
  • -0.030-2.00%
Close Jul 20 16:00 ET
  • 1.462
  • -0.008-0.54%
Post 19:58 ET
2.60MMarket Cap-0.21P/E (TTM)

GRI Bio (GRI) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
Total Operating Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating Expense
-34.35%2.00M
+36.34%2.66M
+57.98%3.37M
+28.36%2.90M
+61.00%3.05M
-3.55%1.95M
-12.67%2.13M
-61.96%2.26M
+91.80%1.90M
+21.54%2.03M
+1211.29%2.44M
+3039.68%5.93M
-62.49%988.00K
--1.67M
--186.00K
--189.00K
--2.63M
Selling and Admin Expenses
+16.37%1.64M
-1.34%1.03M
+58.81%1.60M
-26.23%1.02M
+46.67%1.41M
+6.84%1.05M
-19.60%1.01M
-72.69%1.38M
+10.32%962.00K
-38.98%980.00K
+916.26%1.25M
+3787.69%5.05M
-36.02%872.00K
--1.61M
--123.00K
--130.00K
--1.36M
-General & Admin Expense
+16.37%1.64M
-1.34%1.03M
+58.81%1.60M
-26.23%1.02M
+46.67%1.41M
+6.84%1.05M
-19.60%1.01M
-72.69%1.38M
+10.32%962.00K
-38.98%980.00K
+916.26%1.25M
+3787.69%5.05M
-36.02%872.00K
--1.61M
--123.00K
--130.00K
--1.36M
Research & Development
-77.99%361.00K
+79.82%1.63M
+57.24%1.77M
+114.25%1.88M
+75.78%1.64M
-13.29%907.00K
-5.38%1.13M
-0.34%877.00K
+704.31%933.00K
+1614.75%1.05M
+1787.30%1.19M
+1391.53%880.00K
-90.87%116.00K
--61.00K
--63.00K
--59.00K
--1.27M
Operating Profit
+34.35%-2.00M
-36.34%-2.66M
-57.98%-3.37M
-28.36%-2.90M
-61.00%-3.05M
+3.55%-1.95M
+12.67%-2.13M
+61.96%-2.26M
-91.80%-1.90M
-21.54%-2.03M
-1211.29%-2.44M
-3039.68%-5.93M
+62.49%-988.00K
---1.67M
---186.00K
---189.00K
---2.63M
Net Non-Operating Interest Income (Expense)
+0.00%5.00K
-16.67%5.00K
-14.29%6.00K
-16.67%5.00K
-16.67%5.00K
-14.29%6.00K
+16.67%7.00K
+100.64%6.00K
+100.52%6.00K
+102.53%7.00K
+103.64%6.00K
-781.13%-934.00K
-116100.00%-1.16M
---277.00K
---165.00K
---106.00K
---1.00K
Non-Operating Interest Income
+0.00%5.00K
-16.67%5.00K
-14.29%6.00K
-16.67%5.00K
-16.67%5.00K
--6.00K
--7.00K
--6.00K
--6.00K
----
----
----
----
----
----
----
----
Non-Operating Interest Expense
----
----
----
----
----
----
----
----
----
----
----
+781.13%934.00K
----
----
----
--106.00K
--1.00K
Total Other Finance Costs
----
----
----
----
----
----
-16.67%-7.00K
----
-100.52%-6.00K
----
-103.64%-6.00K
----
--1.16M
----
--165.00K
----
----
Other Income (Expense)
----
----
----
----
----
-100.00%0.00
----
-99.18%1.00K
--2.00K
--15.00K
--296.00K
--122.00K
----
----
----
----
----
Gain on Sale of Security
----
----
----
----
----
----
----
-99.18%1.00K
--2.00K
----
--46.00K
--122.00K
----
----
----
----
----
Other Non-Operating Income (Expenses)
----
----
----
----
----
----
----
----
----
--182.00K
--250.00K
----
----
----
----
----
----
Pretax Profit
+34.41%-2.00M
-36.50%-2.66M
-58.22%-3.36M
-28.53%-2.89M
-61.42%-3.05M
+2.79%-1.95M
+0.66%-2.12M
+66.65%-2.25M
+12.23%-1.89M
+11.68%-2.00M
-508.83%-2.14M
-2186.78%-6.75M
+18.41%-2.15M
---2.27M
---351.00K
---295.00K
---2.64M
Net Profit
+34.41%-2.00M
-36.50%-2.66M
-58.22%-3.36M
-28.53%-2.89M
-61.42%-3.05M
+2.79%-1.95M
+0.66%-2.12M
+66.65%-2.25M
+12.23%-1.89M
+11.68%-2.00M
-508.83%-2.14M
-2186.78%-6.75M
+18.41%-2.15M
---2.27M
---351.00K
---295.00K
---2.64M
Profit from Continuing Operations
+34.41%-2.00M
-36.50%-2.66M
-58.22%-3.36M
-28.53%-2.89M
-61.42%-3.05M
+2.79%-1.95M
+0.66%-2.12M
+66.65%-2.25M
+12.23%-1.89M
+11.68%-2.00M
-508.83%-2.14M
-2186.78%-6.75M
+18.41%-2.15M
---2.27M
---351.00K
---295.00K
---2.64M
Net Income to Parent Company
+34.41%-2.00M
-36.50%-2.66M
-58.22%-3.36M
-28.53%-2.89M
-61.42%-3.05M
+2.79%-1.95M
+0.66%-2.12M
+66.65%-2.25M
+12.23%-1.89M
+11.68%-2.00M
-508.83%-2.14M
-2186.78%-6.75M
+18.41%-2.15M
---2.27M
---351.00K
---295.00K
---2.64M
Net Income to Common Stockholders
+34.41%-2.00M
+31.10%-2.66M
-58.22%-3.36M
-28.53%-2.89M
-61.42%-3.05M
-92.56%-3.86M
+0.66%-2.12M
+66.65%-2.25M
+12.23%-1.89M
+11.68%-2.00M
-508.83%-2.14M
-2186.78%-6.75M
+18.41%-2.15M
---2.27M
---351.00K
---295.00K
---2.64M
Basic EPS
+99.01%-1.61
+97.40%-5.34
+88.79%-35.84
+97.88%-36.68
+95.56%-162.30
+98.93%-205.63
+98.98%-319.76
+98.25%-1.73K
+88.43%-3.66K
+42.25%-19.27K
-508.83%-31.43K
-2186.78%-99.21K
+18.41%-31.62K
---33.37K
---5.16K
---4.34K
---38.75K
Diluted EPS
+99.01%-1.61
+97.40%-5.34
+88.79%-35.84
+97.88%-36.68
+95.56%-162.30
+98.93%-205.63
+98.98%-319.76
+98.25%-1.73K
+88.43%-3.66K
+42.25%-19.27K
-508.83%-31.43K
-2186.78%-99.21K
+18.41%-31.62K
---33.37K
---5.16K
---4.34K
---38.75K
Deadline
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Accounting Standard
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
2026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q1
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Latest: Citing a senior Iranian official, foreign media reported on the 20th that intermediaries in Iran-U.S. negotiations have presented Te Show More